PTKFY
Price
$20.75
Change
+$0.81 (+4.06%)
Updated
Dec 6 closing price
RHHBY
Price
$34.89
Change
+$0.39 (+1.13%)
Updated
Dec 23 closing price
37 days until earnings call
Ad is loading...

PTKFY vs RHHBY

Header iconPTKFY vs RHHBY Comparison
Open Charts PTKFY vs RHHBYBanner chart's image
PT Kalba Farma TBK
Price$20.75
Change+$0.81 (+4.06%)
Volume$671
CapitalizationN/A
Roche Holding
Price$34.89
Change+$0.39 (+1.13%)
Volume$1.59M
CapitalizationN/A
PTKFY vs RHHBY Comparison Chart
Loading...
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTKFY vs. RHHBY commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFY is a Buy and RHHBY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (PTKFY: $20.75 vs. RHHBY: $34.89)
Brand notoriety: PTKFY and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFY: 29% vs. RHHBY: 137%
Market capitalization -- PTKFY: $5.53B vs. RHHBY: $250.69B
PTKFY [@Pharmaceuticals: Major] is valued at $5.53B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFY’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 1 green FA rating(s).

  • PTKFY’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 1 green, 4 red.
According to our system of comparison, PTKFY is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFY’s TA Score shows that 8 TA indicator(s) are bullish while RHHBY’s TA Score has 4 bullish TA indicator(s).

  • PTKFY’s TA Score: 8 bullish, 0 bearish.
  • RHHBY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTKFY is a better buy in the short-term than RHHBY.

Price Growth

PTKFY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -1.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.17%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -3.44%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.17% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) has a higher market cap than PTKFY($5.53B). PTKFY has higher P/E ratio than RHHBY: PTKFY (30.03) vs RHHBY (19.46). RHHBY YTD gains are higher at: 0.255 vs. PTKFY (-27.077). PTKFY has higher annual earnings (EBITDA): 4.85T vs. RHHBY (19.1B). PTKFY has more cash in the bank: 3.63T vs. RHHBY (7.51B). RHHBY has less debt than PTKFY: RHHBY (25.4B) vs PTKFY (889B). PTKFY has higher revenues than RHHBY: PTKFY (29.79T) vs RHHBY (60B).
PTKFYRHHBYPTKFY / RHHBY
Capitalization5.53B251B2%
EBITDA4.85T19.1B25,403%
Gain YTD-27.0770.255-10,629%
P/E Ratio30.0319.46154%
Revenue29.79T60B49,645%
Total Cash3.63T7.51B48,302%
Total Debt889B25.4B3,500%
FUNDAMENTALS RATINGS
PTKFY vs RHHBY: Fundamental Ratings
PTKFY
RHHBY
OUTLOOK RATING
1..100
4710
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
8485
SMR RATING
1..100
1299
PRICE GROWTH RATING
1..100
5659
P/E GROWTH RATING
1..100
4336
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (13) in the null industry is in the same range as PTKFY (27). This means that RHHBY’s stock grew similarly to PTKFY’s over the last 12 months.

PTKFY's Profit vs Risk Rating (84) in the null industry is in the same range as RHHBY (85). This means that PTKFY’s stock grew similarly to RHHBY’s over the last 12 months.

PTKFY's SMR Rating (12) in the null industry is significantly better than the same rating for RHHBY (99). This means that PTKFY’s stock grew significantly faster than RHHBY’s over the last 12 months.

PTKFY's Price Growth Rating (56) in the null industry is in the same range as RHHBY (59). This means that PTKFY’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBY's P/E Growth Rating (36) in the null industry is in the same range as PTKFY (43). This means that RHHBY’s stock grew similarly to PTKFY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFYRHHBY
RSI
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
60%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 1 day ago
38%
Bearish Trend 1 day ago
48%
MACD
ODDS (%)
Bullish Trend 1 day ago
33%
Bearish Trend 1 day ago
47%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
24%
Bearish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
23%
Bearish Trend 1 day ago
50%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
50%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
26%
Bearish Trend 1 day ago
41%
View a ticker or compare two or three
Ad is loading...
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAUX15.410.16
+1.05%
Nationwide GQG US Quality Eq A
VGPMX13.010.12
+0.93%
Vanguard Global Capital Cycles Investor
SBHIX22.830.15
+0.66%
Saratoga Health & Biotechnology I
FKUTX22.530.09
+0.40%
Franklin Utilities A1
DGEZX12.14N/A
N/A
Destinations Equity Income Z

PTKFY and

Correlation & Price change

A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFY
1D Price
Change %
PTKFY100%
N/A
SNPHF - PTKFY
6%
Poorly correlated
N/A
RHHVF - PTKFY
4%
Poorly correlated
+0.08%
RHHBY - PTKFY
2%
Poorly correlated
+1.13%
RHHBF - PTKFY
1%
Poorly correlated
+6.60%
OTSKF - PTKFY
0%
Poorly correlated
N/A
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+1.13%
RHHVF - RHHBY
65%
Loosely correlated
+0.08%
NVS - RHHBY
37%
Loosely correlated
+1.38%
JNJ - RHHBY
37%
Loosely correlated
+0.55%
RHHBF - RHHBY
32%
Poorly correlated
+6.60%
BMY - RHHBY
28%
Poorly correlated
+0.44%
More